ATP6V0E1P1: A Drug Target / Disease Biomarker (G100874502)

Target Name: ATP6V0E1P1

NCBI ID: G100874502

ATP6V0E1P1

Other Name(s): ATPase H+ transporting V0 subunit e1 pseudogene 1

ATP6V0E1P1: A Drug Target / Disease Biomarker

ATP6V0E1P1 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a key regulator of the protein kinase CKL2, which is involved in a wide range of cellular processes, including cell growth, differentiation, and survival.

In recent years, researchers have been interested in investigating the potential drug targets of ATP6V0E1P1. This is because the protein has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease.

One of the key features of ATP6V0E1P1 is its role in the regulation of cell growth and differentiation. This is an important process for the development and maintenance of tissues and organs, and is also involved in the regulation of cell survival.

Research has shown that disruptions in the regulation of cell growth and differentiation can lead to a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. Therefore, targeting the protein ATP6V0E1P1 as a drug target could be a promising approach for the development of new treatments for these diseases.

Another potential drug target for ATP6V0E1P1 is its role in the regulation of cellular signaling pathways. This is a complex process that involves the interaction of a wide range of proteins and other molecules, and is involved in the regulation of a wide range of cellular processes, including cell growth, differentiation, and survival.

Research has shown that disruptions in cellular signaling pathways can lead to a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. Therefore, targeting the protein ATP6V0E1P1 as a drug target could be a promising approach for the development of new treatments for these diseases.

In addition to its role in cell growth and differentiation, ATP6V0E1P1 has also been shown to play a role in the regulation of cellular metabolism. This is an important process that involves the interaction of a wide range of proteins and other molecules, and is involved in the regulation of a wide range of cellular processes, including energy metabolism, cellular signaling pathways, and cellular growth and differentiation.

Research has shown that disruptions in cellular metabolism can lead to a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. Therefore, targeting the protein ATP6V0E1P1 as a drug target could be a promising approach for the development of new treatments for these diseases.

Overall, the protein ATP6V0E1P1 is a promising drug target due to its role in the regulation of cell growth and differentiation, cellular signaling pathways, and cellular metabolism. Further research is needed to fully understand the potential mechanisms of its drug potential and to develop new treatments for the proteins.

Protein Name: ATPase H+ Transporting V0 Subunit E1 Pseudogene 1

The "ATP6V0E1P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ATP6V0E1P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets